MJFF Supports First Study of Anle138b for Parkinson’s
source: pixabay.com

MJFF Supports First Study of Anle138b for Parkinson’s

  Recently, the Michael J. Fox Foundation (MJFF) awarded $1.4 million in funding for Modag, a drug developer whose solutions treat patients with neurodegenerative diseases. In fact, says Parkinson's News…

Continue Reading MJFF Supports First Study of Anle138b for Parkinson’s
An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
source: pixabay.com

An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients

by Danielle Bradshaw from In The Cloud Copy A study was done to figure out how people with Parkinson’s disease coped with the illness in their day to day lives,…

Continue Reading An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
source: pixabay.com

Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients

by Danielle Bradshaw from In The Cloud Copy Information provided by the Michael J. Fox Foundation showed that the majority of patients that had Parkinson’s disease and also contracted COVID-19…

Continue Reading Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease
https://pixabay.com/photos/herbicide-avignon-in-rice-field-587589/

Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease

  Nobody knows the exact cause of Parkinson's disease. However, many researchers believe that environmental triggers may play a factor. Now, the Michael J. Fox Foundation (MJFF) is encouraging American…

Continue Reading Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease
Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19
source: pixabay.com

Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19

Parkinson’s UK is nonprofit organization striving to help Parkinson's disease research continue amidst this global pandemic. Their goal is to get clinical research, and specifically studies that necessitate patients participating…

Continue Reading Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19

ACI-12589 Shows Promise for Diagnosing Parkinson’s and Related Diseases

  At the virtual Alzheimer's Association International Conference (AAIC), AC Immune reported positive preclinical trial data for ACI-12589, their forward-thinking diagnostic tool. ACI-12589 is a non-invasive alpha-synuclein positron emission tomography…

Continue Reading ACI-12589 Shows Promise for Diagnosing Parkinson’s and Related Diseases